Skip to main content

Peer Review reports

From: Cost-effectiveness of first-line immunotherapy combinations with or without chemotherapy for advanced non–small cell lung cancer: a modelling approach

Original Submission
6 Nov 2022 Submitted Original manuscript
4 Feb 2023 Reviewed Reviewer Report
24 Mar 2023 Reviewed Reviewer Report
10 Apr 2023 Author responded Author comments - Yuanyi Cai
26 Apr 2023 Reviewed Reviewer Report
Resubmission - Version 2
10 Apr 2023 Submitted Manuscript version 2
Publishing
9 May 2023 Editorially accepted
15 May 2023 Article published 10.1186/s12885-023-10938-8

You can find further information about peer review here.

Back to article page